查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1870987

人工頸椎間盤市場依產品類型、材質類型、最終用戶和通路分類－2025-2032年全球預測

Artificial Cervical Intervertebral Disc Market by Product Type, Material Type, End User, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，人工頸椎間盤市場規模將達到 79 億美元，複合年成長率為 18.33%。

關鍵市場統計數據
基準年 2024 20.5億美元
預計年份：2025年 24.2億美元
預測年份 2032 79億美元
複合年成長率 (%) 18.33%

本文簡要概述了影響人工頸椎間盤在各相關人員方中發展和應用的臨床、技術和商業性因素。

人工頸椎間盤技術代表了整形外科領域的一個融合創新領域，它匯集了植入設計、生物材料科學、外科技術和醫療保健系統動態，旨在解決頸椎退化性疾病。運動保留裝置的引入正在重塑傳統上嚴重依賴融合手術的治療路徑，促使臨床醫生和醫療保健系統重新評估適應症、患者選擇和長期功能預後。本導言以執行摘要為核心，整合了當前影響該領域的臨床趨勢、技術進步、監管發展和商業性因素。

材料創新、不斷發展的外科技術和價值主導型採購如何共同作用，改變頸椎間盤植入裝置的臨床應用和商業策略

人工頸椎間盤領域經歷了數次變革，這些變革加速了創新，同時也為商業化帶來了新的挑戰。首先，生物材料科學的成熟使得人工頸椎間盤的結構從傳統的金屬對金屬結構過渡到含有高度交聯聚合物配方的複合材料，旨在減少顆粒碎片並提高長期耐久性。材料技術的進步也推動了植入物幾何形狀的相應改進，設計者強調保持一致的關節活動度和限制活動範圍，以在不影響穩定性的前提下保留生理運動。

評估美國關稅調整對頸椎間盤供應彈性、定價策略和採購趨勢的多方面影響

美國宣布的2025年關稅調整對人工頸椎間盤生態系統產生了多方面的影響，波及供應鏈、定價策略和策略採購決策。對於依賴跨境採購原料、精密零件和成品的製造商而言，關稅變化加劇了到岸成本的波動性，迫使其進行更積極的成本建模和情境規劃。為此，許多公司正在重新審視其供應商組合，並加快近岸外包和在地化生產的步伐，以維持利潤率並確保可預測的交貨時間。

細分市場主導的策略挑戰，將產品設計、生物材料選擇、臨床環境和分銷模式與差異化的商業性成果連結起來。

市場區隔洞察揭示了產品、材料、終端用戶和分銷管道等各個維度上的差異化機會和針對性策略選擇。從產品類型來看，球窩式人工椎間盤旨在提供可重複的旋轉運動，可能適用於以維持多軸運動為優先考慮的適應症。緩衝式人工椎間盤著重於減震和負荷分佈，適用於具有特定動態特徵的患者。髓核置換式人工椎間盤旨在恢復局部椎間盤高度並將負荷轉移至中心位置，適用於特定適應症。這些差異會影響臨床定位、手術技術訓練以及製造商優先考慮的療效證據類型。

區域法規結構、臨床能力和供應鏈生態系統如何影響關鍵全球區域的首選市場進入順序和證據策略

臨床實務、監管方式和供應鏈物流方面的區域差異，導致各主要地區在醫療器材應用趨勢上有顯著差異。在美洲，成熟的臨床網路和以結果為導向的採購政策要求製造商證明其產品具有切實的功能優勢和手術全期效率。報銷機制和醫院採購委員會主導醫療器材的選擇，而區域供應鏈中心則支援快速分銷和即時庫存模式。同時，歐洲、中東和非洲地區的情況則更為複雜，各國監管路徑、公共採購流程和私部門滲透率的差異，既為市場准入和規模化帶來了機遇，也帶來了挑戰。一些國家的國家衛生技術評估流程強調療效比較數據和成本效益，引導製造商投資於針對特定國家的證據產生。

老牌企業與創新企業之間的競爭和策略行為會影響產品採納曲線、證據產生和供應商聯盟。

人工頸椎間盤市場的競爭格局呈現出多元化的特點，既有成熟的整形外科公司、脊椎器械專家，也有不斷推出新材料和新設計概念的新興創新者。現有企業擁有規模優勢、製造技術專長和成熟的臨床合作關係，並透過提供包括外科醫生培訓、器械消毒支援和資金籌措協助在內的廣泛服務來維持市場佔有率。新興企業則傾向於專注於臨床差異化，例如新型聚合物組合、模組化設計或簡化的器械，這些都可能為患者帶來特定的手術和治療益處。

一套綜合性的實用策略舉措，旨在幫助製造商和供應商提升產品差異化、供應鏈韌性和實證商業化能力。

產業領導者應抓住機遇，透過一系列協作努力，協調產品開發、實證實踐和商業性韌性，從而擴大產品應用範圍。首先，應優先考慮將臨床差異化設計特徵與具有成熟耐磨性和安全性的材料結合的開發路徑。重點在於採用高交聯聚乙烯 (HCPE) 或超高分子量聚乙烯 (UHMWPE) 的金屬對聚合物 (MoP) 方案，既能解決臨床醫生關注的關鍵問題，又能支持長期療效追蹤。同時，應建構產品系列，並確保行銷和培訓活動與外科醫生的工作流程和患者選擇標準相符。

我們以透明的方式概述了我們的多源研究途徑，該方法整合了臨床醫生意見、監管審查和商業性洞察，以檢驗策略見解。

本分析整合了對骨科醫生、採購主管和供應鏈專業人員的訪談、對監管指南和臨床文獻的系統性回顧以及上市後數據趨勢，從而全面了解人工頸椎間盤的動態變化。主要研究包括結構化訪談，檢驗臨床應用案例，了解植入選擇決策因素，並了解採購部門對近期關稅變化的反應。次要研究則納入了同行評審的臨床文章、醫療設備標籤資訊和公開的監管文件，以確保與當前的安全性和有效性考慮保持一致。

整合相互依存的臨床、商業性和政策因素，這些因素將決定頸椎間盤生態系統中的持續應用和策略定位。

總之，人工頸椎間盤的創新正在材料、動態、手術技術和商業策略等多個領域不斷發展，為製造商、臨床醫生和醫療保健系統創造了一個充滿活力的環境。聚合物技術的進步、精密的關節設計以及越來越多接受過運動功能保留手術培訓的臨床醫生相互交織，共同推動人工頸椎間盤在特定患者群體中的選擇性應用。同時，關稅變化和區域監管差異等外部壓力迫使供應商在製造地的策略佈局、定價策略以及實證醫學投入方面採取更具策略性的措施。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 用於提高頸椎間盤耐磨性的PEEK/金屬複合材料的創新
  • 為恢復椎間盤高度，對新一代椎核置換方案的需求激增
  • 智慧感測器頸椎間盤的應用日益廣泛，以實現術後運動追蹤。
  • 擴大保險覆蓋範圍，以支持年輕患者接受人工頸全人工椎間盤置換術
  • 採用新型生物相容性水凝膠的頸椎間盤植入獲得加速監管核准
  • 人們對使用3D列印技術特異性患者頸椎間盤以改善解剖結構貼合度的興趣日益濃厚。
  • 臨床上努力減少人工頸椎間盤植入術後鄰近椎間盤的退化
  • 整形外科器械製造商與人工智慧公司合作，最佳化人工椎間盤的設計和性能
  • 越來越多的長期追蹤研究評估頸椎人工椎間盤的磨損顆粒和骨溶解情況
  • 為頸椎人工椎間盤引入抗菌表面塗層，以最大限度降低術後感染風險

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 人工頸椎間盤市場（依產品類型分類）

  • 球窩式人工椎間盤
  • 椎間盤呈墊狀。
  • 髓核置換人工椎間盤

第9章 人工頸椎間盤市場（依材料類型分類）

  • 金屬對金屬
  • 金屬與聚合物
    • 高交聯聚乙烯
    • 超高分子量聚乙烯
  • 聚合物與聚合物

第10章 依最終用戶分類的人工頸椎間盤市場

  • 門診手術中心
  • 醫院
    • 私立醫院
    • 公立醫院
  • 專業整形外科中心

第11章 人工頸椎間盤市場（依通路分類）

  • 直銷
  • 批發的

第12章 人工頸椎間盤市場：依地區分類

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 人工頸椎間盤市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國人工頸椎間盤市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • DePuy Synthes, Inc.
    • Medtronic plc
    • Stryker Corporation
    • Zimmer Biomet Holdings, Inc.
    • NuVasive, Inc.
    • Globus Medical, Inc.
    • Orthofix Medical Inc.
    • Centinel Spine, LLC
    • B. Braun Melsungen AG
    • Medacta International SA
Product Code: MRR-1A1A064C053A

The Artificial Cervical Intervertebral Disc Market is projected to grow by USD 7.90 billion at a CAGR of 18.33% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 2.05 billion
Estimated Year [2025] USD 2.42 billion
Forecast Year [2032] USD 7.90 billion
CAGR (%) 18.33%

A concise framing of clinical, technological, and commercial drivers reshaping artificial cervical intervertebral disc development and adoption across stakeholder groups

Artificial cervical intervertebral disc technologies represent a convergent area of orthopedic innovation, where implant design, biomaterials science, surgical technique, and health system dynamics intersect to address degenerative cervical spine conditions. The introduction of motion-preserving devices has reframed therapeutic pathways that historically relied heavily on fusion, prompting clinicians and health systems to reassess indications, patient selection, and long-term functional outcomes. This introduction anchors an executive summary that synthesizes clinical trends, technology evolution, regulatory trajectories, and commercial forces shaping the segment today.

Over recent years, device designers have pursued refined articulating geometries, alternative material pairings, and modular constructs intended to optimize kinematics and reduce wear. Concurrently, surgeons have broadened their armamentarium by integrating cervical disc replacement into treatment algorithms for appropriate patient cohorts, while payers and hospitals evaluate comparative value versus fusion in terms of rehabilitation, adjacent segment disease, and resource utilization. This section frames the broader context in which product innovation and stakeholder decision-making occur, highlighting the interplay between clinical evidence generation, surgeon training, and procurement dynamics.

The remainder of the summary unpacks the most consequential shifts impacting adoption, the implications of recent tariff policies in the United States, segmentation-based insights that inform commercialization tactics, regional patterns in clinical practice and supply chain resilience, profiles of influential corporate players, recommended actions for industry leaders, and a transparent description of the methodology underpinning the analysis.

How materials innovation, surgical technique evolution, and value-driven procurement are jointly transforming clinical adoption and commercial strategies for cervical disc devices

The landscape for artificial cervical intervertebral discs has experienced several transformative shifts that collectively accelerate innovation while also introducing new complexity for commercialization. First, the maturation of biomaterials science has enabled a move beyond traditional metal-on-metal constructs toward polymer-inclusive pairings and highly cross-linked formulations designed to reduce particulate debris and improve long-term durability. These material advances have driven parallel refinements in implant geometry, with designers emphasizing congruent articulations and constrained mobility tailored to preserve physiological motion without compromising stability.

Second, surgical technique and perioperative pathways have evolved in tandem with device innovation. Surgeons are more systematically integrating preoperative imaging analytics and intraoperative navigation to optimize implant positioning and alignment, which in turn improves functional outcomes and device survival. Enhanced training programs and proctoring models have lowered the barriers to adoption among spine specialists, while multidisciplinary care pathways have refined patient selection criteria to better match device profile to clinical indication.

Third, reimbursement and value assessment paradigms are shifting toward evidence-based comparisons that consider total episode outcomes. Health systems increasingly emphasize comparative effectiveness studies and real-world evidence to inform procurement, which elevates the importance of post-market surveillance and registries. Lastly, supply chain agility and manufacturing scalability have become strategic priorities as firms balance regulatory compliance, cost pressures, and the need for geographically diversified production to mitigate logistic risks.

Evaluating the multifaceted consequences of the United States tariff adjustments on supply resilience, pricing strategy, and procurement dynamics within the cervical disc sector

Recent tariff adjustments announced in the United States in 2025 have imparted a multifaceted impact on the artificial cervical intervertebral disc ecosystem, influencing supply chains, pricing strategy, and strategic sourcing decisions. For manufacturers reliant on cross-border supply of raw materials, precision components, or finished devices, tariff changes have introduced additional landed cost variability that necessitates more proactive cost modeling and scenario planning. In response, many firms have re-evaluated their supplier portfolios and accelerated nearshoring or regional manufacturing initiatives to preserve margins and maintain predictable delivery timelines.

Procurement teams within hospitals and specialty centers have reacted by intensifying contract negotiations and by seeking greater transparency around total cost of care rather than focusing solely on unit price. As a result, vendors are emphasizing bundled service offerings, longer-term value propositions, and outcomes-based agreements that can mitigate the short-term pricing friction introduced by tariffs. At the same time, regulatory and customs compliance activities have scaled up within corporate functions to manage tariff classification risk and to identify eligible exemptions or free trade mechanisms.

Clinicians and hospital administrators have felt secondary effects as supply variability and cost pressures influence purchasing cadence and stocking policies. To maintain access to preferred implants, clinical teams have collaborated more closely with supply chain and finance partners to forecast case volumes and ensure continuity of care. Collectively, these shifts underscore the need for integrated commercial strategies that align pricing, supply resilience, and clinical value arguments in a tariff-sensitive operating environment.

Segment-driven strategic imperatives that connect product architectures, biomaterial selection, clinical settings, and distribution models to differentiated commercial outcomes

Insight into market segmentation reveals differentiated opportunities and targeted strategic choices across product, material, end user, and distribution dimensions. From a product type perspective, Ball And Socket Disc designs emphasize replicating rotational kinematics and may appeal where multi-axis motion preservation is prioritized, Cushion Disc architectures focus on shock absorption and load distribution suited to patients with particular biomechanical profiles, and Nucleus Replacement Disc concepts target focal restoration of disc height and central load transfer for select indications. These distinctions inform clinical positioning, surgical technique training, and the types of outcome evidence manufacturers prioritize.

Material type segmentation further refines design trade-offs. Metal On Metal constructs historically offered strength and low deformation but raised concerns about wear particles. Metal On Polymer combinations have become prominent because they offer a balance of strength and wear reduction, and within that grouping there is specific attention to Highly Cross-Linked Polyethylene and Ultra-High-Molecular-Weight Polyethylene as polymer options that improve wear characteristics and longevity. Polymer On Polymer pairings present an alternative route toward low-friction interfaces and have the potential to reduce metal exposure in sensitive patient populations.

End user segmentation reveals divergent procurement and utilization patterns. Ambulatory Surgical Centers often prioritize implants that enable streamlined procedural workflows and rapid recovery, Hospitals accommodate a broader case mix and encompass both Private Hospital and Public Hospital procurement dynamics that influence purchasing cycles and contract structures, while Specialty Orthopedic Centers demand devices supported by robust clinical evidence and surgeon training. Finally, distribution channel choices-Direct Sales versus Distributor Sales-shape commercial touchpoints, service models, and margin structures, and they influence how manufacturers deploy field clinical specialists, training curricula, and post-market surveillance programs.

How regional regulatory frameworks, clinical capacity, and supply chain ecosystems shape prioritized market entry sequencing and evidence strategies across major global geographies

Regional patterns in clinical practice, regulatory approaches, and supply chain logistics yield meaningful variation in adoption dynamics across major geographies. In the Americas, established clinical networks and a focus on outcome-driven procurement exert pressure on manufacturers to demonstrate tangible functional benefits and perioperative efficiencies; reimbursement frameworks and hospital purchasing committees shape device selection, while supply chain hubs in the region support rapid distribution and just-in-time inventory models. Meanwhile, Europe, Middle East & Africa presents a heterogeneous landscape where national regulatory pathways, public procurement processes, and varying levels of private sector penetration create both opportunities and complexity for market entry and scale-up. National health technology assessment processes in some countries emphasize comparative effectiveness data and cost-effectiveness, directing manufacturers to invest in country-specific evidence generation.

In the Asia-Pacific region, expanding surgical capacity, increasing procedure volumes, and a growing base of trained spine surgeons are contributing to a more dynamic market environment. Local manufacturing ecosystems and regional component suppliers offer pathways to cost-competitive production, while fragmented payer systems and disparate regulatory requirements necessitate tailored commercialization approaches. Across all regions, clinicians and health systems demonstrate greater appetite for data-driven decision-making, which amplifies the importance of post-market registries and multicenter outcome studies that can be leveraged to support reimbursement discussions and surgeon adoption strategies. These regional insights should inform prioritization of clinical studies, manufacturing footprints, and market entry sequencing.

Competitive dynamics and strategic behaviors among established firms and innovators that influence adoption curves, evidence generation, and supplier partnerships

The competitive fabric of the artificial cervical intervertebral disc landscape is characterized by a mix of established orthopedic firms, specialized spine device companies, and emerging innovators that introduce new materials and design philosophies. Incumbent players bring scale, manufacturing expertise, and established clinical relationships, and they often leverage broad service offerings such as surgeon education, instrument sterilization support, and financing arrangements to maintain share. Emerging companies frequently compete on focused clinical differentiation-such as novel polymer pairings, modularity, or simplified instrumentation-that can deliver specific surgical or patient benefits.

Strategic activity among these companies includes progressive clinical evidence generation, targeted post-market studies, and iterative product refinements based on real-world feedback. Partnerships and selective licensing agreements are common pathways for mid-sized firms seeking to access global distribution networks or to complement their R&D capabilities. At the same time, several players are investing in digital capabilities that enhance implant tracking, patient-reported outcome capture, and remote follow-up, thereby strengthening long-term value propositions. For purchasers and hospital systems, evaluating vendor ecosystems now requires attention not only to implant performance but also to the breadth of clinician support, registry participation, and the supplier's ability to navigate tariff-impacted supply chains and local regulatory requirements.

An integrated set of pragmatic and strategic actions for manufacturers and suppliers to strengthen product differentiation, supply chain resilience, and evidence-backed commercialization

Industry leaders should pursue a set of coordinated actions that align product development, evidence generation, and commercial resilience to capitalize on evolving adoption windows. First, prioritize development paths that marry clinically differentiated design features with materials that offer demonstrable wear and safety benefits; focusing on Metal On Polymer options that utilize Highly Cross-Linked Polyethylene or Ultra-High-Molecular-Weight Polyethylene can address key clinician concerns while supporting longer-term outcomes tracking. Simultaneously, tailor product portfolios to reflect the clinical nuances among Ball And Socket Disc, Cushion Disc, and Nucleus Replacement Disc archetypes so that marketing and training efforts are congruent with surgeon workflows and patient selection criteria.

Second, fortify supply chain and tariff risk management by diversifying supplier bases, evaluating regional manufacturing partnerships, and embedding customs and trade expertise into commercial planning. Third, strengthen post-market evidence generation through registries and multicenter collaborations that span key regions, enhancing the ability to engage payers and hospital systems with comparative effectiveness insights. Fourth, adapt go-to-market models by balancing Direct Sales investments with selective Distributor Sales where partners can provide local regulatory navigation and inventory support, thereby enabling broader reach while preserving high-quality clinician engagement.

Finally, invest in digital tools and services that improve the clinician experience, facilitate patient follow-up, and provide outcome analytics that support reimbursement conversations. By executing these actions in an integrated manner, organizations can create defensible pathways for adoption that withstand pricing and policy pressures while delivering demonstrable clinical value.

A transparent overview of the multi-source research approach that integrates clinician input, regulatory review, and commercial intelligence to validate strategic insights

This analysis synthesizes primary interviews with orthopedic surgeons, procurement leaders, and supply chain specialists, structured reviews of regulatory guidance and clinical literature, and post-market data trends to construct a comprehensive perspective on artificial cervical intervertebral disc dynamics. Primary engagement included structured conversations to validate clinical use cases, understand decision drivers for implant selection, and capture procurement responses to recent tariff changes. Secondary research incorporated peer-reviewed clinical publications, device labeling information, and publicly available regulatory communications to ensure alignment with current safety and efficacy considerations.

The methodological approach intentionally layered qualitative insights with observed commercial behaviors to reconcile surgeon preferences, hospital purchasing patterns, and regional regulatory nuances. Segmentation analysis drew on clinical device attributes and established distribution models to delineate where differentiated product strategies and market access investments deliver the greatest returns. Regional analysis integrated local practice patterns and manufacturing footprints to identify pragmatic pathways for scaling distribution and evidence generation. Throughout the research process, findings were triangulated across sources to enhance validity and to provide actionable guidance for decision-makers focused on clinical adoption, supply resilience, and long-term value delivery.

A synthesis of the interdependent clinical, commercial, and policy factors that will determine durable adoption and strategic positioning in the cervical disc ecosystem

In conclusion, artificial cervical intervertebral disc innovation is advancing on multiple fronts-materials, biomechanics, surgical technique, and commercial strategy-creating a dynamic environment for manufacturers, clinicians, and health systems. The interplay between improved polymer technologies, refined articulating designs, and an expanding clinician base trained in motion-preserving procedures supports selective adoption across appropriate patient populations. At the same time, external pressures such as tariff changes and regional regulatory diversity require vendors to be more strategic about manufacturing footprints, pricing approaches, and evidence generation investments.

Decision-makers should view these dynamics as an opportunity to differentiate through demonstrable clinical value, robust post-market surveillance, and flexible commercial models that address both Direct Sales and Distributor Sales channels. By aligning product development with the clinical realities of Ball And Socket Disc, Cushion Disc, and Nucleus Replacement Disc use cases, and by prioritizing material choices that improve wear characteristics, organizations can strengthen their propositions to hospitals, ambulatory centers, and specialty orthopedic providers. Ultimately, success will hinge on the ability to integrate clinical excellence with supply chain foresight and payer-aligned evidence strategies to secure durable adoption and improved patient outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Innovation in PEEK-on-metal composites for enhanced wear resistance in cervical discs
  • 5.2. Surge in demand for next-generation nucleus replacement options to restore disc height
  • 5.3. Increased adoption of smart sensor-enabled cervical discs for postoperative motion tracking
  • 5.4. Expansion of insurance coverage policies supporting artificial cervical disc replacement in younger patients
  • 5.5. Regulatory fast-track approvals for novel biocompatible hydrogels in cervical disc implants
  • 5.6. Growing interest in patient-specific 3D printed cervical discs to improve anatomical fit
  • 5.7. Clinical focus on reducing adjacent segment degeneration following artificial cervical disc implantation
  • 5.8. Collaborations between orthopedic device makers and AI firms to optimize disc design and performance
  • 5.9. Rising number of long-term outcome studies evaluating wear particles and osteolysis in cervical discs
  • 5.10. Emergence of antibacterial surface coatings on cervical discs to minimize postoperative infection risks

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Artificial Cervical Intervertebral Disc Market, by Product Type

  • 8.1. Ball And Socket Disc
  • 8.2. Cushion Disc
  • 8.3. Nucleus Replacement Disc

9. Artificial Cervical Intervertebral Disc Market, by Material Type

  • 9.1. Metal On Metal
  • 9.2. Metal On Polymer
    • 9.2.1. Highly Cross-Linked Polyethylene
    • 9.2.2. Ultra-High-Molecular-Weight Polyethylene
  • 9.3. Polymer On Polymer

10. Artificial Cervical Intervertebral Disc Market, by End User

  • 10.1. Ambulatory Surgical Center
  • 10.2. Hospital
    • 10.2.1. Private Hospital
    • 10.2.2. Public Hospital
  • 10.3. Specialty Orthopedic Center

11. Artificial Cervical Intervertebral Disc Market, by Distribution Channel

  • 11.1. Direct Sales
  • 11.2. Distributor Sales

12. Artificial Cervical Intervertebral Disc Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Artificial Cervical Intervertebral Disc Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Artificial Cervical Intervertebral Disc Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. DePuy Synthes, Inc.
    • 15.3.2. Medtronic plc
    • 15.3.3. Stryker Corporation
    • 15.3.4. Zimmer Biomet Holdings, Inc.
    • 15.3.5. NuVasive, Inc.
    • 15.3.6. Globus Medical, Inc.
    • 15.3.7. Orthofix Medical Inc.
    • 15.3.8. Centinel Spine, LLC
    • 15.3.9. B. Braun Melsungen AG
    • 15.3.10. Medacta International SA

LIST OF FIGURES

  • FIGURE 1. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY BALL AND SOCKET DISC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY BALL AND SOCKET DISC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY BALL AND SOCKET DISC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY BALL AND SOCKET DISC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY BALL AND SOCKET DISC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY BALL AND SOCKET DISC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY CUSHION DISC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY CUSHION DISC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY CUSHION DISC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY CUSHION DISC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY CUSHION DISC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY CUSHION DISC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY NUCLEUS REPLACEMENT DISC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY NUCLEUS REPLACEMENT DISC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY NUCLEUS REPLACEMENT DISC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY NUCLEUS REPLACEMENT DISC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY NUCLEUS REPLACEMENT DISC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY NUCLEUS REPLACEMENT DISC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON METAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON METAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON METAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON METAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON METAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON METAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON POLYMER, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON POLYMER, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON POLYMER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON POLYMER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON POLYMER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON POLYMER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON POLYMER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON POLYMER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HIGHLY CROSS-LINKED POLYETHYLENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HIGHLY CROSS-LINKED POLYETHYLENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HIGHLY CROSS-LINKED POLYETHYLENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HIGHLY CROSS-LINKED POLYETHYLENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HIGHLY CROSS-LINKED POLYETHYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HIGHLY CROSS-LINKED POLYETHYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY ULTRA-HIGH-MOLECULAR-WEIGHT POLYETHYLENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY ULTRA-HIGH-MOLECULAR-WEIGHT POLYETHYLENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY ULTRA-HIGH-MOLECULAR-WEIGHT POLYETHYLENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY ULTRA-HIGH-MOLECULAR-WEIGHT POLYETHYLENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY ULTRA-HIGH-MOLECULAR-WEIGHT POLYETHYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY ULTRA-HIGH-MOLECULAR-WEIGHT POLYETHYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY POLYMER ON POLYMER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY POLYMER ON POLYMER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY POLYMER ON POLYMER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY POLYMER ON POLYMER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY POLYMER ON POLYMER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY POLYMER ON POLYMER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HOSPITAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRIVATE HOSPITAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRIVATE HOSPITAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRIVATE HOSPITAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRIVATE HOSPITAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PUBLIC HOSPITAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PUBLIC HOSPITAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PUBLIC HOSPITAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PUBLIC HOSPITAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY SPECIALTY ORTHOPEDIC CENTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY SPECIALTY ORTHOPEDIC CENTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY SPECIALTY ORTHOPEDIC CENTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY SPECIALTY ORTHOPEDIC CENTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY SPECIALTY ORTHOPEDIC CENTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY SPECIALTY ORTHOPEDIC CENTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DISTRIBUTOR SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DISTRIBUTOR SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DISTRIBUTOR SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DISTRIBUTOR SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. AMERICAS ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 110. AMERICAS ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 111. AMERICAS ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 112. AMERICAS ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 113. AMERICAS ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 114. AMERICAS ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 115. AMERICAS ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON POLYMER, 2018-2024 (USD MILLION)
  • TABLE 116. AMERICAS ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON POLYMER, 2025-2032 (USD MILLION)
  • TABLE 117. AMERICAS ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 118. AMERICAS ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 119. AMERICAS ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 120. AMERICAS ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 121. AMERICAS ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 122. AMERICAS ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. NORTH AMERICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 126. NORTH AMERICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 128. NORTH AMERICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON POLYMER, 2018-2024 (USD MILLION)
  • TABLE 130. NORTH AMERICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON POLYMER, 2025-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 132. NORTH AMERICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 134. NORTH AMERICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 136. NORTH AMERICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. LATIN AMERICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 140. LATIN AMERICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 142. LATIN AMERICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON POLYMER, 2018-2024 (USD MILLION)
  • TABLE 144. LATIN AMERICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON POLYMER, 2025-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 146. LATIN AMERICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 148. LATIN AMERICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 150. LATIN AMERICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON POLYMER, 2018-2024 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON POLYMER, 2025-2032 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 165. EUROPE ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. EUROPE ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. EUROPE ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 168. EUROPE ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 169. EUROPE ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 170. EUROPE ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 171. EUROPE ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON POLYMER, 2018-2024 (USD MILLION)
  • TABLE 172. EUROPE ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON POLYMER, 2025-2032 (USD MILLION)
  • TABLE 173. EUROPE ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 174. EUROPE ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 175. EUROPE ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 176. EUROPE ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 177. EUROPE ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 178. EUROPE ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. MIDDLE EAST ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. MIDDLE EAST ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 182. MIDDLE EAST ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 183. MIDDLE EAST ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 184. MIDDLE EAST ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 185. MIDDLE EAST ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON POLYMER, 2018-2024 (USD MILLION)
  • TABLE 186. MIDDLE EAST ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON POLYMER, 2025-2032 (USD MILLION)
  • TABLE 187. MIDDLE EAST ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 188. MIDDLE EAST ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 189. MIDDLE EAST ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 190. MIDDLE EAST ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 191. MIDDLE EAST ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 192. MIDDLE EAST ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 193. AFRICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. AFRICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. AFRICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 196. AFRICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 197. AFRICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 198. AFRICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 199. AFRICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON POLYMER, 2018-2024 (USD MILLION)
  • TABLE 200. AFRICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON POLYMER, 2025-2032 (USD MILLION)
  • TABLE 201. AFRICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 202. AFRICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 203. AFRICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 204. AFRICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 205. AFRICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 206. AFRICA ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 207. ASIA-PACIFIC ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. ASIA-PACIFIC ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. ASIA-PACIFIC ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 210. ASIA-PACIFIC ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 211. ASIA-PACIFIC ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 212. ASIA-PACIFIC ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 213. ASIA-PACIFIC ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON POLYMER, 2018-2024 (USD MILLION)
  • TABLE 214. ASIA-PACIFIC ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON POLYMER, 2025-2032 (USD MILLION)
  • TABLE 215. ASIA-PACIFIC ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 216. ASIA-PACIFIC ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 217. ASIA-PACIFIC ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 218. ASIA-PACIFIC ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 219. ASIA-PACIFIC ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 220. ASIA-PACIFIC ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 223. ASEAN ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. ASEAN ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. ASEAN ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 226. ASEAN ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 227. ASEAN ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 228. ASEAN ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 229. ASEAN ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON POLYMER, 2018-2024 (USD MILLION)
  • TABLE 230. ASEAN ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON POLYMER, 2025-2032 (USD MILLION)
  • TABLE 231. ASEAN ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 232. ASEAN ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 233. ASEAN ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 234. ASEAN ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 235. ASEAN ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 236. ASEAN ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 237. GCC ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 238. GCC ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 239. GCC ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 240. GCC ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 241. GCC ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 242. GCC ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 243. GCC ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON POLYMER, 2018-2024 (USD MILLION)
  • TABLE 244. GCC ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON POLYMER, 2025-2032 (USD MILLION)
  • TABLE 245. GCC ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 246. GCC ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 247. GCC ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 248. GCC ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 249. GCC ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 250. GCC ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPEAN UNION ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPEAN UNION ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPEAN UNION ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPEAN UNION ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPEAN UNION ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPEAN UNION ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPEAN UNION ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON POLYMER, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPEAN UNION ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON POLYMER, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPEAN UNION ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPEAN UNION ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPEAN UNION ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPEAN UNION ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPEAN UNION ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPEAN UNION ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 265. BRICS ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. BRICS ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. BRICS ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. BRICS ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 269. BRICS ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 270. BRICS ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 271. BRICS ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON POLYMER, 2018-2024 (USD MILLION)
  • TABLE 272. BRICS ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY METAL ON POLYMER, 2025-2032 (USD MILLION)
  • TABLE 273. BRICS ARTIFICIAL CERVICAL INTERVERTEBRAL DISC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)

TAB